Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
6.05
+0.54 (9.80%)
At close: Feb 18, 2026, 4:00 PM EST
6.07
+0.02 (0.33%)
After-hours: Feb 18, 2026, 4:00 PM EST
Verrica Pharmaceuticals Market Cap
Verrica Pharmaceuticals has a market cap or net worth of $96.74 million as of February 18, 2026. Its market cap has increased by 64.94% in one year.
Market Cap
96.74M
Enterprise Value
102.74M
1-Year Change
64.94%
Ranking
Category
Stock Price
$6.05
Market Cap Chart
Since June 15, 2018, Verrica Pharmaceuticals's market cap has decreased from $436.56M to $96.74M, a decrease of -77.84%. That is a compound annual growth rate of -17.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 88.10M | -33.69% |
| Dec 31, 2025 | 132.88M | 109.60% |
| Dec 31, 2024 | 63.40M | -79.41% |
| Dec 29, 2023 | 307.91M | 172.47% |
| Dec 30, 2022 | 113.01M | -55.17% |
| Dec 31, 2021 | 252.07M | -15.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dogwood Therapeutics | 102.05M |
| Actuate Therapeutics | 99.71M |
| Equillium | 99.26M |
| aTyr Pharma | 97.99M |
| Anixa Biosciences | 97.13M |
| Turn Therapeutics | 96.43M |
| Cognition Therapeutics | 96.22M |
| Precision BioSciences | 92.19M |